Trial Profile
Ezetimibe lipid loWering Trial On PreventIon of Atherosclerosis in 75 or older
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2020
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia; Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms EWTOPIA75
- 03 Jun 2020 Status changed from discontinued to completed.
- 22 Aug 2019 Results published in the Circulation
- 27 Apr 2016 Status changed from active, no longer recruiting to discontinued.